Castle Biosciences (CSTL) Other Gross PP&E Adjustments (2018 - 2025)
Historic Other Gross PP&E Adjustments for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to $86.6 million.
- Castle Biosciences' Other Gross PP&E Adjustments rose 9696.27% to $86.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.6 million, marking a year-over-year increase of 9696.27%. This contributed to the annual value of $47.2 million for FY2024, which is 18084.06% up from last year.
- According to the latest figures from Q3 2025, Castle Biosciences' Other Gross PP&E Adjustments is $86.6 million, which was up 9696.27% from $74.1 million recorded in Q2 2025.
- In the past 5 years, Castle Biosciences' Other Gross PP&E Adjustments registered a high of $86.6 million during Q3 2025, and its lowest value of $421000.0 during Q1 2022.
- In the last 5 years, Castle Biosciences' Other Gross PP&E Adjustments had a median value of $15.3 million in 2023 and averaged $25.9 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first plummeted by 9564.5% in 2022, then skyrocketed by 284014.25% in 2023.
- Over the past 5 years, Castle Biosciences' Other Gross PP&E Adjustments (Quarter) stood at $3.0 million in 2021, then skyrocketed by 85.7% to $5.5 million in 2022, then surged by 206.24% to $16.8 million in 2023, then soared by 180.84% to $47.2 million in 2024, then surged by 83.25% to $86.6 million in 2025.
- Its Other Gross PP&E Adjustments stands at $86.6 million for Q3 2025, versus $74.1 million for Q2 2025 and $58.5 million for Q1 2025.